BTMD

Biote Corp. Class A Common Stock
Data: 2026-01-30
$2.09
Price
-0.48%
Change
$5.74
52W High
$2.03
52W Low

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.

Quick Stats
Jan 30, 2026

55.0

AI Score

HOLD

0.82

Volume Ratio

Mar 11, 2026

Next Earnings

10

+ve Days (30d)

16

-ve Days (30d)

BTMD Stock Summary

Last updated Jan 30, 2026

BTMD is currently trading at $2.09, positioned below its 200-day moving average of $3.22, suggesting bearish momentum. The stock has a 52-week range of $2.03 to $5.74.

Technical Analysis: The 50-day moving average stands at $2.51, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 29.748, suggesting the stock is oversold and potentially undervalued.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.109, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates BTMD at 55.0/100 with a HOLD recommendation.

BTMD (Biote Corp. Class A Common Stock) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 29.748
CMF (20) -0.109
ROC (10) -12.552
ADX (14) 37.808
Indicator Value
MACD (12,26,9) -0.134
AROONOSC (14) -92.857
WILLAMS %R (14) -90.323
MFI (14) 19.216
BTMD Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

BTMD Price vs Max Options Open Interest
BTMD Max Change In Options Open Interest

BTMD Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BTMD Daily Out of Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BTMD Daily In the Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BTMD Most Active Options by Volume(near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Biote Corp. Class A Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

BTMD Moving Averages Analysis

BTMD (Biote Corp. Class A Common Stock) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 2.19
20 2.33
30 2.45
50 2.51
100 2.73
200 3.22

BTMD Fundamental Analysis

P/E (Forward) 5.3591
P/E (Trailing) 2.6456
Market Cap ($) 100.0 million
Earnings/Share ($) 0.79
Net Proft Margin (%) 0.1472
Dividend/Share ($) --
EPS Estimate Current Year ($) 0.68
EPS Estimate Next Year ($) 0.83
WallStreet Target Price ($) 4.212
Most Recent Quarter